This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Humira
  • /
  • A Phase 2 Multicenter, Randomized, Placebo- and Ac...
Clinical trial

A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis (X-PLORE)

Read time: 2 mins
Last updated:1st Nov 2011
Identifier: NCT01483599
The purpose of this study is to evaluate the efficacy and safety of CNTO 1959 in the treatment of patients with moderate to severe plaque psoriasis.

 

Category Value
Date last updated at source 2016-03-29
Study type(s) Interventional
Expected enrolment 293
Study start date 2011-11-01
Estimated primary completion date 2013-08-01

View full details